» Articles » PMID: 39960900

Mapping the Knowledge of Omics in Myocardial Infarction: A Scientometric Analysis in R Studio, VOSviewer, Citespace, and SciMAT

Overview
Specialty General Medicine
Date 2025 Feb 17
PMID 39960900
Authors
Affiliations
Soon will be listed here.
Abstract

Many researchers nowadays choose multi-omics techniques for myocardial infarction studies. However, there's yet to be a review article integrating myocardial infarction multi-omics. Hence, this study adopts the popular bibliometrics. Based on its principles, we use software like R Studio, Vosviewer, Citespace, and SciMAT to analyze literature data of myocardial infarction omics research (1991-2022) from Web of Science. By extracting key information and calculating weights, we conduct analyses from 4 aspects: Collaboration Network Analysis, Co-word Analysis, Citing and Cited Journal Analysis, and Co-citation and Clustering Analysis, aiming to understand the field's cooperation, research topic evolution, and knowledge flow. The results show that myocardial infarction omics research is still in its early stage with limited international cooperation. In terms of knowledge flow, there's no significant difference within the discipline, but non-biomedical disciplines have joined, indicating an interdisciplinary integration trend. In the overall research field, genomics remains the main topic with many breakthroughs identifying susceptibility sites. Meanwhile, other omics fields like lipidomics and proteomics are also progressing, clarifying the pathogenesis. The cooperation details in this article enable researchers to connect with others, facilitating their research. The evolution trend of subject terms helps them set goals and directions, quickly grasp the development context, and read relevant literature. Journal analysis offers submission suggestions, and the analysis of research base and frontier provides references for the research's future development.

References
1.
Padmanabhan Iyer R, Patterson N, Zouein F, Ma Y, Dive V, de Castro Bras L . Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution. Int J Cardiol. 2015; 185:198-208. PMC: 4406852. DOI: 10.1016/j.ijcard.2015.03.054. View

2.
Petersen S, Abdulkareem M, Leiner T . Artificial Intelligence Will Transform Cardiac Imaging-Opportunities and Challenges. Front Cardiovasc Med. 2019; 6:133. PMC: 6746883. DOI: 10.3389/fcvm.2019.00133. View

3.
Magavern E, Kaski J, Turner R, Drexel H, Janmohamed A, Scourfield A . The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2021; 8(1):85-99. DOI: 10.1093/ehjcvp/pvab018. View

4.
DeLeon-Pennell K, Tian Y, Zhang B, Cates C, Padmanabhan Iyer R, Cannon P . CD36 Is a Matrix Metalloproteinase-9 Substrate That Stimulates Neutrophil Apoptosis and Removal During Cardiac Remodeling. Circ Cardiovasc Genet. 2015; 9(1):14-25. PMC: 4758866. DOI: 10.1161/CIRCGENETICS.115.001249. View

5.
Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes T, Thompson J . Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2012; 45(1):25-33. PMC: 3679547. DOI: 10.1038/ng.2480. View